| Year |
Citation |
Score |
| 2020 |
Bongiovanni D, Tosello V, Saccomani V, Dalla Santa S, Amadori A, Zanovello P, Piovan E. Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia. Oncogene. 39: 6544-6555. PMID 32917954 DOI: 10.1038/S41388-020-01453-2 |
0.375 |
|
| 2020 |
Tosello V, Bongiovanni D, Liu J, Pan Q, Yan KK, Saccomani V, Van Trimpont M, Pizzi M, Mazzoni M, Dei Tos AP, Amadori A, Zanovello P, Van Vlierberghe P, Yu J, Piovan E. Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia dissemination. Leukemia. PMID 32733009 DOI: 10.1038/S41375-020-0999-2 |
0.395 |
|
| 2020 |
Saccomani V, Grassi A, Piovan E, Bongiovanni D, Di Martino L, Minuzzo S, Tosello V, Zanovello P. miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia. Cells. 9. PMID 32708470 DOI: 10.3390/Cells9071726 |
0.411 |
|
| 2019 |
Scaini MC, Pigozzo J, Pizzi M, Manicone M, Chiarion-Sileni V, Zambenedetti P, Rugge M, Zanovello P, Rossi E, Zamarchi R, Facchinetti A. Clonal heterogeneity of melanoma in a paradigmatic case study: future prospects for circulating melanoma cells. Melanoma Research. 29: 89-94. PMID 30222690 DOI: 10.1097/Cmr.0000000000000510 |
0.309 |
|
| 2018 |
Piovan E, Tosello V, Amadori A, Zanovello P. Chemotactic Cues for NOTCH1-Dependent Leukemia. Frontiers in Immunology. 9: 633. PMID 29666622 DOI: 10.3389/Fimmu.2018.00633 |
0.386 |
|
| 2018 |
Bordin F, Piovan E, Masiero E, Ambesi-Impiombato A, Minuzzo S, Bertorelle R, Sacchetto V, Pilotto G, Basso G, Zanovello P, Amadori A, Tosello V. loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia. Haematologica. 103: 266-277. PMID 29170254 DOI: 10.3324/Haematol.2017.170431 |
0.448 |
|
| 2017 |
Tosi A, Dalla Santa S, Cappuzzello E, Marotta C, Walerych D, Del Sal G, Zanovello P, Sommaggio R, Rosato A. Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1. Oncoimmunology. 6: e1313371. PMID 28919988 DOI: 10.1080/2162402X.2017.1313371 |
0.453 |
|
| 2017 |
Cappuzzello E, Sommaggio R, Zanovello P, Rosato A. Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells. Cytokine & Growth Factor Reviews. 36: 99-105. PMID 28629761 DOI: 10.1016/J.Cytogfr.2017.06.003 |
0.492 |
|
| 2017 |
Turrini R, Merlo A, Martorelli D, Faè DA, Sommaggio R, Montagner IM, Barbieri V, Marin O, Zanovello P, Dolcetti R, Rosato A. A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors. Oncoimmunology. 6: e1304338. PMID 28507812 DOI: 10.1080/2162402X.2017.1304338 |
0.452 |
|
| 2016 |
Marigo I, Zilio S, Desantis G, Mlecnik B, Agnellini AH, Ugel S, Sasso MS, Qualls JE, Kratochvill F, Zanovello P, Molon B, Ries CH, Runza V, Hoves S, Bilocq AM, et al. T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells. Cancer Cell. 30: 651. PMID 27728809 DOI: 10.1016/J.Ccell.2016.09.009 |
0.432 |
|
| 2016 |
Marigo I, Zilio S, Desantis G, Mlecnik B, Agnellini AH, Ugel S, Sasso MS, Qualls JE, Kratochvill F, Zanovello P, Molon B, Ries CH, Runza V, Hoves S, Bilocq AM, et al. T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells. Cancer Cell. 30: 377-90. PMID 27622331 DOI: 10.1016/J.Ccell.2016.08.004 |
0.434 |
|
| 2016 |
Cappuzzello E, Tosi A, Zanovello P, Sommaggio R, Rosato A. Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies. Oncoimmunology. 5: e1199311. PMID 27622068 DOI: 10.1080/2162402X.2016.1199311 |
0.487 |
|
| 2016 |
Montagner IM, Merlo A, Carpanese D, Dalla Pietà A, Mero A, Grigoletto A, Loregian A, Renier D, Campisi M, Zanovello P, Pasut G, Rosato A. A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 236: 79-89. PMID 27356018 DOI: 10.1016/J.Jconrel.2016.06.033 |
0.318 |
|
| 2016 |
Merlo A, Dalla Santa S, Dolcetti R, Zanovello P, Rosato A. Reverse immunoediting: When immunity is edited by antigen. Immunology Letters. 175: 16-20. PMID 27131431 DOI: 10.1016/J.Imlet.2016.04.015 |
0.4 |
|
| 2016 |
Cappuzzello E, Tosi A, Zanovello P, Sommaggio R, Rosato A. Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies Oncoimmunology. 5. DOI: 10.1080/2162402X.2016.1199311 |
0.379 |
|
| 2015 |
Mazzocco M, Martini M, Rosato A, Stefani E, Matucci A, Dalla Santa S, De Sanctis F, Ugel S, Sandri S, Ferrarini G, Cestari T, Ferrari S, Zanovello P, Bronte V, Sartoris S. Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma. Immunology. PMID 25959091 DOI: 10.1111/Imm.12477 |
0.416 |
|
| 2014 |
Montagner IM, Merlo A, Zuccolotto G, Renier D, Campisi M, Pasut G, Zanovello P, Rosato A. Peritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugs. Plos One. 9: e112240. PMID 25383653 DOI: 10.1371/Journal.Pone.0112240 |
0.393 |
|
| 2014 |
Zuccolotto G, Fracasso G, Merlo A, Montagner IM, Rondina M, Bobisse S, Figini M, Cingarlini S, Colombatti M, Zanovello P, Rosato A. PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models. Plos One. 9: e109427. PMID 25279468 DOI: 10.1371/Journal.Pone.0109427 |
0.437 |
|
| 2014 |
Dalla Santa S, Merlo A, Bobisse S, Ronconi E, Boldrin D, Milan G, Barbieri V, Marin O, Facchinetti A, Biasi G, Dolcetti R, Zanovello P, Rosato A. Functional avidity-driven activation-induced cell death shapes CTL immunodominance. Journal of Immunology (Baltimore, Md. : 1950). 193: 4704-11. PMID 25246498 DOI: 10.4049/Jimmunol.1303203 |
0.455 |
|
| 2014 |
Ruggero K, Guffanti A, Corradin A, Sharma VK, De Bellis G, Corti G, Grassi A, Zanovello P, Bronte V, Ciminale V, D'Agostino DM. Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase. Journal of Virology. 88: 3612-22. PMID 24403582 DOI: 10.1128/Jvi.02823-13 |
0.412 |
|
| 2014 |
Bisognin A, Pizzini S, Perilli L, Esposito G, Mocellin S, Nitti D, Zanovello P, Bortoluzzi S, Mandruzzato S. An integrative framework identifies alternative splicing events in colorectal cancer development. Molecular Oncology. 8: 129-41. PMID 24189147 DOI: 10.1016/J.Molonc.2013.10.004 |
0.307 |
|
| 2013 |
Alaggio R, Turrini R, Boldrin D, Merlo A, Gambini C, Ferrari A, Dall'igna P, Coffin CM, Martines A, Bonaldi L, De Salvo GL, Zanovello P, Rosato A. Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST). Plos One. 8: e80456. PMID 24303016 DOI: 10.1371/Journal.Pone.0080456 |
0.305 |
|
| 2013 |
Sonda N, Simonato F, Peranzoni E, Calì B, Bortoluzzi S, Bisognin A, Wang E, Marincola FM, Naldini L, Gentner B, Trautwein C, Sackett SD, Zanovello P, Molon B, Bronte V. miR-142-3p prevents macrophage differentiation during cancer-induced myelopoiesis. Immunity. 38: 1236-49. PMID 23809164 DOI: 10.1016/J.Immuni.2013.06.004 |
0.324 |
|
| 2013 |
Montagner IM, Banzato A, Zuccolotto G, Renier D, Campisi M, Bassi P, Zanovello P, Rosato A. Paclitaxel-hyaluronan hydrosoluble bioconjugate: mechanism of action in human bladder cancer cell lines. Urologic Oncology. 31: 1261-9. PMID 22341413 DOI: 10.1016/J.Urolonc.2012.01.005 |
0.343 |
|
| 2013 |
Rossi E, Facchinetti A, Grassi A, Rossi CR, Stragliotto S, Pigozzo J, Chiarion-Sileni V, Amadori A, Zanovello P, Zamarchi R. Potential applications of circulating melanoma cells (CMCs) expressing γ-H2AX. Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E22036 |
0.355 |
|
| 2012 |
D'Agostino DM, Zanovello P, Watanabe T, Ciminale V. The microRNA regulatory network in normal- and HTLV-1-transformed T cells. Advances in Cancer Research. 113: 45-83. PMID 22429852 DOI: 10.1016/B978-0-12-394280-7.00002-6 |
0.421 |
|
| 2011 |
Turrini R, Merlo A, Dolcetti R, Zanovello P, Rosato A. Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer. Cancer Immunology, Immunotherapy : Cii. 60: 1639-45. PMID 21833593 DOI: 10.1007/S00262-011-1086-3 |
0.443 |
|
| 2011 |
Solito S, Falisi E, Diaz-Montero CM, Doni A, Pinton L, Rosato A, Francescato S, Basso G, Zanovello P, Onicescu G, Garrett-Mayer E, Montero AJ, Bronte V, Mandruzzato S. A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood. 118: 2254-65. PMID 21734236 DOI: 10.1182/Blood-2010-12-325753 |
0.454 |
|
| 2011 |
Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, Mussolin L, Ruggero K, Bonanno L, Guffanti A, De Bellis G, Gerosa G, Stellin G, D'Agostino DM, Basso G, ... ... Zanovello P, et al. Modulation of microRNA expression in human T-cell development: Targeting of NOTCH3 by miR-150 Blood. 117: 7053-7062. PMID 21551231 DOI: 10.1182/Blood-2010-12-326629 |
0.364 |
|
| 2011 |
Nardo G, Favaro E, Curtarello M, Moserle L, Zulato E, Persano L, Rossi E, Esposito G, Crescenzi M, Casanovas O, Sattler U, Mueller-Klieser W, Biesalski B, Thews O, Canese R, ... ... Zanovello P, et al. Glycolytic phenotype and AMP kinase modify the pathologic response of tumor xenografts to VEGF neutralization Cancer Research. 71: 4214-4225. PMID 21546569 DOI: 10.1158/0008-5472.Can-11-0242 |
0.337 |
|
| 2011 |
Biasi G, Facchinetti A, Cappellari R, Rossi E, Zanovello P. Immune response to Moloney-murine leukemia virus-induced antigens in bone marrow. Immunology Letters. 138: 79-85. PMID 21453727 DOI: 10.1016/J.Imlet.2011.03.005 |
0.394 |
|
| 2011 |
Merlo A, Turrini R, Dolcetti R, Zanovello P, Rosato A. Immunotherapy for EBV-associated malignancies. International Journal of Hematology. 93: 281-293. PMID 21336546 DOI: 10.1007/S12185-011-0782-2 |
0.345 |
|
| 2011 |
D'Agostino DM, Ruggero K, Biasiolo M, Bortoluzzi S, Pise-Masison CA, Corradin A, Basso K, Guffanti A, Bellis GD, Corti G, Zanovello P, Bronte V, Ciminale V. MicroRNA expression in HTLV-1 infection and pathogenesis Retrovirology. 8: 1-1. DOI: 10.1186/1742-4690-8-S1-A156 |
0.392 |
|
| 2010 |
Merlo A, Turrini R, Trento C, Zanovello P, Dolcetti R, Rosato A. Impact of γ-chain cytokines on EBV-specific T cell cultures. Journal of Translational Medicine. 8: 121. PMID 21092174 DOI: 10.1186/1479-5876-8-121 |
0.396 |
|
| 2010 |
Marigo I, Bosio E, Solito S, Mesa C, Fernandez A, Dolcetti L, Ugel S, Sonda N, Bicciato S, Falisi E, Calabrese F, Basso G, Zanovello P, Cozzi E, Mandruzzato S, et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity. 32: 790-802. PMID 20605485 DOI: 10.1016/J.Immuni.2010.05.010 |
0.453 |
|
| 2010 |
Ruggero K, Corradin A, Zanovello P, Amadori A, Bronte V, Ciminale V, D'Agostino DM. Role of microRNAs in HTLV-1 infection and transformation. Molecular Aspects of Medicine. 31: 367-82. PMID 20600265 DOI: 10.1016/J.Mam.2010.05.001 |
0.409 |
|
| 2010 |
Merlo A, Turrini R, Bobisse S, Zamarchi R, Alaggio R, Dolcetti R, Mautner J, Zanovello P, Amadori A, Rosato A. Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors. Journal of Immunology (Baltimore, Md. : 1950). 184: 5895-902. PMID 20385879 DOI: 10.4049/Jimmunol.0902850 |
0.428 |
|
| 2010 |
Martini M, Testi MG, Pasetto M, Picchio MC, Innamorati G, Mazzocco M, Ugel S, Cingarlini S, Bronte V, Zanovello P, Krampera M, Mosna F, Cestari T, Riviera AP, Brutti N, et al. IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer. Vaccine. 28: 3548-57. PMID 20304037 DOI: 10.1016/J.Vaccine.2010.03.007 |
0.346 |
|
| 2010 |
Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, Bronte V. Myeloid-derived suppressor cell heterogeneity and subset definition. Current Opinion in Immunology. 22: 238-44. PMID 20171075 DOI: 10.1016/J.Coi.2010.01.021 |
0.445 |
|
| 2010 |
Ugel S, Scarselli E, Iezzi M, Mennuni C, Pannellini T, Calvaruso F, Cipriani B, De Palma R, Ricci-Vitiani L, Peranzoni E, Musiani P, Zanovello P, Bronte V. Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes. Blood. 115: 1374-84. PMID 19903903 DOI: 10.1182/Blood-2009-07-233270 |
0.498 |
|
| 2009 |
Bobisse S, Rondina M, Merlo A, Tisato V, Mandruzzato S, Amendola M, Naldini L, Willemsen RA, Debets R, Zanovello P, Rosato A. Reprogramming T lymphocytes for melanoma adoptive immunotherapy by T-cell receptor gene transfer with lentiviral vectors. Cancer Research. 69: 9385-94. PMID 19996290 DOI: 10.1158/0008-5472.Can-09-0494 |
0.473 |
|
| 2009 |
Ugel S, Zoso A, De Santo C, Li Y, Marigo I, Zanovello P, Scarselli E, Cipriani B, Oelke M, Schneck JP, Bronte V. In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer. Cancer Research. 69: 9376-84. PMID 19934317 DOI: 10.1158/0008-5472.Can-09-0400 |
0.493 |
|
| 2009 |
Mandruzzato S, Solito S, Falisi E, Francescato S, Chiarion-Sileni V, Mocellin S, Zanon A, Rossi CR, Nitti D, Bronte V, Zanovello P. IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. Journal of Immunology (Baltimore, Md. : 1950). 182: 6562-8. PMID 19414811 DOI: 10.4049/Jimmunol.0803831 |
0.477 |
|
| 2008 |
Mennuni C, Ugel S, Mori F, Cipriani B, Iezzi M, Pannellini T, Lazzaro D, Ciliberto G, La Monica N, Zanovello P, Bronte V, Scarselli E. Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer. Cancer Research. 68: 9865-74. PMID 19047167 DOI: 10.1158/0008-5472.Can-08-1603 |
0.395 |
|
| 2008 |
Merlo A, Turrini R, Dolcetti R, Zanovello P, Amadori A, Rosato A. Adoptive cell therapy against EBV-related malignancies: a survey of clinical results. Expert Opinion On Biological Therapy. 8: 1265-94. PMID 18694349 DOI: 10.1517/14712598.8.9.1265 |
0.396 |
|
| 2008 |
Banzato A, Bobisse S, Rondina M, Renier D, Bettella F, Esposito G, Quintieri L, Meléndez-Alafort L, Mazzi U, Zanovello P, Rosato A. A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent in vivo therapeutic activity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3598-606. PMID 18519794 DOI: 10.1158/1078-0432.Ccr-07-2019 |
0.4 |
|
| 2008 |
Dolcetti L, Marigo I, Mantelli B, Peranzoni E, Zanovello P, Bronte V. Myeloid-derived suppressor cell role in tumor-related inflammation. Cancer Letters. 267: 216-25. PMID 18433992 DOI: 10.1016/J.Canlet.2008.03.012 |
0.377 |
|
| 2008 |
Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunological Reviews. 222: 162-79. PMID 18364001 DOI: 10.1111/J.1600-065X.2008.00602.X |
0.408 |
|
| 2007 |
Bobisse S, Zanovello P, Rosato A. T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy. Expert Opinion On Biological Therapy. 7: 893-906. PMID 17555374 DOI: 10.1517/14712598.7.6.893 |
0.404 |
|
| 2006 |
Gallina G, Dolcetti L, Serafini P, De Santo C, Marigo I, Colombo MP, Basso G, Brombacher F, Borrello I, Zanovello P, Bicciato S, Bronte V. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. The Journal of Clinical Investigation. 116: 2777-90. PMID 17016559 DOI: 10.1172/Jci28828 |
0.475 |
|
| 2006 |
Bronte V, Cingarlini S, Marigo I, De Santo C, Gallina G, Dolcetti L, Ugel S, Peranzoni E, Mandruzzato S, Zanovello P. Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention. Immunological Investigations. 35: 327-57. PMID 16916757 DOI: 10.1080/08820130600754994 |
0.414 |
|
| 2006 |
Rosato A, Banzato A, De Luca G, Renier D, Bettella F, Pagano C, Esposito G, Zanovello P, Bassi P. HYTAD1-p20: A new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer{star, open} Urologic Oncology: Seminars and Original Investigations. 24: 207-215. PMID 16678050 DOI: 10.1016/J.Urolonc.2005.08.020 |
0.354 |
|
| 2006 |
Rosato A, Pivetta M, Parenti A, Iaderosa GA, Zoso A, Milan G, Mandruzzato S, Del Bianco P, Ruol A, Zaninotto G, Zanovello P. Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma. International Journal of Cancer. 119: 1717-22. PMID 16671090 DOI: 10.1002/Ijc.21923 |
0.303 |
|
| 2006 |
Rosato A, Zoso A, Dalla Santa S, Milan G, Del Bianco P, De Salvo GL, Zanovello P. Predicting tumor outcome following cancer vaccination by monitoring quantitative and qualitative CD8+ T cell parameters. Journal of Immunology (Baltimore, Md. : 1950). 176: 1999-2006. PMID 16424232 DOI: 10.4049/Jimmunol.176.3.1999 |
0.455 |
|
| 2005 |
Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nature Reviews. Immunology. 5: 641-54. PMID 16056256 DOI: 10.1038/Nri1668 |
0.31 |
|
| 2005 |
De Santo C, Serafini P, Marigo I, Dolcetti L, Bolla M, Del Soldato P, Melani C, Guiducci C, Colombo MP, Iezzi M, Musiani P, Zanovello P, Bronte V. Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination. Proceedings of the National Academy of Sciences of the United States of America. 102: 4185-90. PMID 15753302 DOI: 10.1073/Pnas.0409783102 |
0.438 |
|
| 2005 |
Quintieri L, Geroni C, Fantin M, Battaglia R, Rosato A, Speed W, Zanovello P, Floreani M. Formation and antitumor activity of PNU-159682, a major metabolite of nemorubicin in human liver microsomes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 1608-17. PMID 15746066 DOI: 10.1158/1078-0432.Ccr-04-1845 |
0.351 |
|
| 2005 |
Nagorsen D, Deola S, Smith K, Wang E, Monsurro V, Zanovello P, Marincola FM, Panelli MC. Polarized monocyte response to cytokine stimulation. Genome Biology. 6: R15. PMID 15693944 DOI: 10.1186/Gb-2005-6-2-R15 |
0.307 |
|
| 2005 |
Mocellin S, Mandruzzato S, Zanovello P, Bronte V. Cancer rejection by the immune system: Forcing the check-points of tumor immune escape Drug Discovery Today: Disease Mechanisms. 2: 191-197. DOI: 10.1016/J.Ddmec.2005.05.016 |
0.394 |
|
| 2004 |
De Palma R, Marigo I, Del Galdo F, De Santo C, Serafini P, Cingarlini S, Tüting T, Lenz J, Basso G, Milan G, Zanovello P, Bronte V. Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes. Cancer Research. 64: 8068-76. PMID 15520218 DOI: 10.1158/0008-5472.Can-04-0067 |
0.429 |
|
| 2004 |
Wang E, Panelli MC, Zavaglia K, Mandruzzato S, Hu N, Taylor PR, Seliger B, Zanovello P, Freedman RS, Marincola FM. Melanoma-restricted genes. Journal of Translational Medicine. 2: 34. PMID 15488140 DOI: 10.1186/1479-5876-2-34 |
0.373 |
|
| 2004 |
Serafini P, De Santo C, Marigo I, Cingarlini S, Dolcetti L, Gallina G, Zanovello P, Bronte V. Derangement of immune responses by myeloid suppressor cells. Cancer Immunology, Immunotherapy : Cii. 53: 64-72. PMID 14593498 DOI: 10.1007/S00262-003-0443-2 |
0.517 |
|
| 2003 |
Bronte V, Cingarlini S, Apolloni E, Serafini P, Marigo I, De Santo C, Macino B, Marin O, Zanovello P. Effective genetic vaccination with a widely shared endogenous retroviral tumor antigen requires CD40 stimulation during tumor rejection phase. Journal of Immunology (Baltimore, Md. : 1950). 171: 6396-405. PMID 14662838 DOI: 10.4049/Jimmunol.171.12.6396 |
0.424 |
|
| 2003 |
Rosato A, Zoso A, Milan G, Macino B, Dalla Santa S, Tosello V, Di Carlo E, Musiani P, Whalen RG, Zanovello P. Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacy. Journal of Immunology (Baltimore, Md. : 1950). 171: 5172-9. PMID 14607917 DOI: 10.4049/Jimmunol.171.10.5172 |
0.476 |
|
| 2003 |
Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends in Immunology. 24: 302-6. PMID 12810105 DOI: 10.1016/S1471-4906(03)00132-7 |
0.446 |
|
| 2003 |
Rosato A, Dalla Santa S, Zoso A, Giacomelli S, Milan G, Macino B, Tosello V, Dellabona P, Lollini PL, De Giovanni C, Zanovello P. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus. Cancer Research. 63: 2158-63. PMID 12727834 |
0.386 |
|
| 2003 |
Bronte V, Serafini P, De Santo C, Marigo I, Tosello V, Mazzoni A, Segal DM, Staib C, Lowel M, Sutter G, Colombo MP, Zanovello P. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. Journal of Immunology (Baltimore, Md. : 1950). 170: 270-8. PMID 12496409 DOI: 10.4049/Jimmunol.170.1.270 |
0.512 |
|
| 2002 |
Mandruzzato S, Rossi E, Bernardi F, Tosello V, Macino B, Basso G, Chiarion-Sileni V, Rossi CR, Montesco C, Zanovello P. Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient. Journal of Immunology (Baltimore, Md. : 1950). 169: 4017-24. PMID 12244204 DOI: 10.4049/Jimmunol.169.7.4017 |
0.428 |
|
| 2002 |
Mazzoni A, Bronte V, Visintin A, Spitzer JH, Apolloni E, Serafini P, Zanovello P, Segal DM. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. Journal of Immunology (Baltimore, Md. : 1950). 168: 689-95. PMID 11777962 DOI: 10.4049/Jimmunol.168.2.689 |
0.482 |
|
| 2001 |
Bronte V, Serafini P, Apolloni E, Zanovello P. Tumor-induced immune dysfunctions caused by myeloid suppressor cells. Journal of Immunotherapy. 24: 431-446. PMID 11759067 DOI: 10.1097/00002371-200111000-00001 |
0.486 |
|
| 2001 |
Dalerba P, Frascella E, Macino B, Mandruzzato S, Zambon A, Rosolen A, Carli M, Ninfo V, Zanovello P. MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas. International Journal of Cancer. 93: 85-90. PMID 11391626 DOI: 10.1002/Ijc.1307 |
0.361 |
|
| 2000 |
Rosato A, Milan G, Zambon A, Zanovello P, Collavo D. CTL Analysis for Tumor Vaccines. Methods in Molecular Medicine. 29: 123-32. PMID 21374315 DOI: 10.1385/1-59259-688-6:123 |
0.697 |
|
| 2000 |
Apolloni E, Bronte V, Mazzoni A, Serafini P, Cabrelle A, Segal DM, Young HA, Zanovello P. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 165: 6723-30. PMID 11120790 DOI: 10.4049/Jimmunol.165.12.6723 |
0.492 |
|
| 2000 |
Bronte V, Apolloni E, Cabrelle A, Ronca R, Serafini P, Zamboni P, Restifo NP, Zanovello P. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood. 96: 3838-46. PMID 11090068 DOI: 10.1182/Blood.V96.12.3838 |
0.443 |
|
| 1999 |
Rosato A, Milan G, Collavo D, Zanovello P. DNA-based vaccination against tumors expressing the P1A antigen. Methods (San Diego, Calif.). 19: 187-90. PMID 10525455 DOI: 10.1006/Meth.1999.0844 |
0.631 |
|
| 1999 |
Quintieri L, Rosato A, Amboldi N, Vizler C, Ballinari D, Zanovello P, Collavo D. Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases. British Journal of Cancer. 79: 1067-73. PMID 10098738 DOI: 10.1038/Sj.Bjc.6690171 |
0.658 |
|
| 1999 |
Milan G, Zambon A, Cavinato M, Zanovello P, Rosato A, Collavo D. Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach. Journal of Virology. 73: 2280-7. PMID 9971811 DOI: 10.1128/Jvi.73.3.2280-2287.1999 |
0.686 |
|
| 1998 |
Milan G, Rosato A, Zambon A, Zanovello P, Collavo D. DNA immunization in mice against virus-induced tumor antigens. Advances in Experimental Medicine and Biology. 451: 311-4. PMID 10026889 DOI: 10.1007/978-1-4615-5357-1_48 |
0.688 |
|
| 1998 |
Vizler C, Rosato A, Calderazzo F, Quintieri L, Fruscella P, Wainstok de Calmanovici R, Mantovani A, Vecchi A, Zanovello P, Collavo D. Therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased anti-tumour cytotoxic T-lymphocyte activity. British Journal of Cancer. 77: 656-62. PMID 9484826 DOI: 10.1038/Bjc.1998.105 |
0.69 |
|
| 1997 |
Rosato A, Zambon A, Milan G, Ciminale V, D'Agostino DM, Macino B, Zanovello P, Collavo D. CTL response and protection against P815 tumor challenge in mice immunized with DNA expressing the tumor-specific antigen P815A. Human Gene Therapy. 8: 1451-8. PMID 9287145 DOI: 10.1089/Hum.1997.8.12-1451 |
0.686 |
|
| 1996 |
Macino B, Zambon A, Milan G, Cabrelle A, Ruzzene M, Rosato A, Mandruzzato S, Quintieri L, Zanovello P, Collavo D. CD45 regulates apoptosis induced by extracellular adenosine triphosphate and cytotoxic T lymphocytes. Biochemical and Biophysical Research Communications. 226: 769-76. PMID 8831688 DOI: 10.1006/Bbrc.1996.1427 |
0.661 |
|
| 1996 |
Monastra G, Cabrelle A, Zambon A, Rosato A, Macino B, Collavo D, Zanovello P. Membrane form of TNF alpha induces both cell lysis and apoptosis in susceptible target cells. Cellular Immunology. 171: 102-10. PMID 8660844 DOI: 10.1006/Cimm.1996.0179 |
0.654 |
|
| 1996 |
Rosato A, Zambon A, Macino B, Mandruzzato S, Bronte V, Milan G, Zanovello P, Collavo D. Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area. International Journal of Cancer. 65: 847-51. PMID 8631602 DOI: 10.1002/(Sici)1097-0215(19960315)65:6<847::Aid-Ijc23>3.0.Co;2-# |
0.675 |
|
| 1996 |
Bronte V, Macino B, Zambon A, Rosato A, Mandruzzato S, Zanovello P, Collavo D. Protein tyrosine kinases and phosphatases control apoptosis induced by extracellular adenosine 5'-triphosphate. Biochemical and Biophysical Research Communications. 218: 344-51. PMID 8573158 DOI: 10.1006/Bbrc.1996.0060 |
0.619 |
|
| 1995 |
Rosato A, Mandruzzato S, Bronte V, Zambon A, Macino B, Calderazzo F, Zanovello P, Collavo D. Role of anti-LFA-1 and anti-ICAM-1 combined MAb treatment in the rejection of tumors induced by Moloney murine sarcoma virus (M-MSV). International Journal of Cancer. 61: 355-62. PMID 7729948 DOI: 10.1002/Ijc.2910610314 |
0.7 |
|
| 1994 |
Zambon A, Bronte V, Di Virgilio F, Hanau S, Steinberg TH, Collavo D, Zanovello P. Role of extracellular ATP in cell-mediated cytotoxicity: a study with ATP-sensitive and ATP-resistant macrophages. Cellular Immunology. 156: 458-67. PMID 8025958 DOI: 10.1006/Cimm.1994.1190 |
0.654 |
|
| 1994 |
Rosato A, Zambon A, Mandruzzato S, Bronte V, Macino B, Calderazzo F, Collavo D, Zanovello P. Inhibition of protein tyrosine phosphorylation prevents T-cell-mediated cytotoxicity. Cellular Immunology. 159: 294-305. PMID 7994761 DOI: 10.1006/Cimm.1994.1315 |
0.696 |
|
| 1993 |
Bronte V, Zanovello P, Rosato A, Zambon A, Mandruzzato S, Pizzo P, Di Virgilio F, Collavo D. Synergistic effect of extracellular adenosine 5'-triphosphate and tumor necrosis factor on DNA degradation. Cellular Immunology. 152: 110-9. PMID 8242754 DOI: 10.1006/Cimm.1993.1271 |
0.669 |
|
| 1992 |
Zanovello P, Rosato A, Bronte V, Mandruzzato S, Cerundolo V, Collavo D. Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases. Cancer Immunology, Immunotherapy : Cii. 35: 27-32. PMID 1611620 DOI: 10.1007/Bf01741051 |
0.729 |
|
| 1992 |
Pollis F, Bronte V, Mandruzzato S, Rosato A, Zambon A, Zanovello P, Zambello R, Callegaro L, Collavo D. Inhibition of CTL-line lysis after gangliosides treatment. Pharmacological Research. 26: 190-1. PMID 1409305 DOI: 10.1016/1043-6618(92)90659-Y |
0.586 |
|
| 1992 |
Mandruzzato S, Rosato A, Bronte V, Pollis F, Zambon A, Zanovello P, Collavo D. Therapeutical effect of 4'-deoxy-4'-iododoxorubicin-loaded LAK cells in mice bearing lung metastases. Pharmacological Research. 26: 124-5. PMID 1409274 DOI: 10.1016/1043-6618(92)90628-O |
0.632 |
|
| 1991 |
Mandruzzato S, Rosato A, Bronte V, Pollis F, Zambon A, Zanovello P, Collavo D. Therapeutical effect of adriamycin- and iododoxorubicin-treated LAK cells in mice bearing lung metastases European Journal of Cancer and Clinical Oncology. 27. DOI: 10.1016/0277-5379(91)91379-W |
0.642 |
|
| 1990 |
Di Virgilio F, Pizzo P, Zanovello P, Bronte V, Collavo D. Extracellular ATP as a possible mediator of cell-mediated cytotoxicity. Immunology Today. 11: 274-7. PMID 2206271 DOI: 10.1016/0167-5699(90)90111-L |
0.686 |
|
| 1990 |
Virgilio FD, Picello E, Bronte V, Zanovello P, Collavo D. Extracellular ATP Causes Changes in Plasma Membrane Permeability of Mouse Lymphocytesa Annals of the New York Academy of Sciences. 603: 427-428. DOI: 10.1111/J.1749-6632.1990.Tb37691.X |
0.56 |
|
| 1989 |
Zanovello P, Cerundolo V, Bronte V, Giunta M, Panozzo M, Biasi G, Collavo D. Resistance of lymphokine-activated T lymphocytes to cell-mediated cytotoxicity. Cellular Immunology. 122: 450-60. PMID 2788517 DOI: 10.1016/0008-8749(89)90091-9 |
0.751 |
|
| 1989 |
Zanovello P, Rosato A, Bronte V, Cerundolo V, Treves S, Di Virgilio F, Pozzan T, Biasi G, Collavo D. Interaction of lymphokine-activated killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosis. The Journal of Experimental Medicine. 170: 665-77. PMID 2769181 DOI: 10.1084/Jem.170.3.665 |
0.708 |
|
| 1989 |
Biasi G, Mazzocchi M, Zanovello P, Collavo D, Festenstein H. In vitro induction of immunological tolerance. Cellular Immunology. 124: 187-201. PMID 2531040 DOI: 10.1016/0008-8749(89)90124-X |
0.713 |
|
| 1988 |
Amadori A, Faulkner-Valle GP, De Rossi A, Zanovello P, Collavo D, Chieco-Bianchi L. HIV-mediated immunodepression: in vitro inhibition of T-lymphocyte proliferative response by ultraviolet-inactivated virus. Clinical Immunology and Immunopathology. 46: 37-54. PMID 3257177 DOI: 10.1016/0090-1229(88)90004-9 |
0.686 |
|
| 1987 |
Treves S, Di Virgilio F, Cerundolo V, Zanovello P, Collavo D, Pozzan T. Calcium and inositolphosphates in the activation of T cell-mediated cytotoxicity. The Journal of Experimental Medicine. 166: 33-42. PMID 3036996 DOI: 10.1084/Jem.166.1.33 |
0.717 |
|
| 1987 |
Cerundolo V, Lahaye T, Horvath C, Zanovello P, Collavo D, Engers HD. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone. European Journal of Immunology. 17: 173-8. PMID 3030766 DOI: 10.1002/Eji.1830170204 |
0.775 |
|
| 1987 |
Cerundolo V, Zanovello P, McIntosh D, Fabbris R, Davies AJ, Collavo D. Temporary inhibition of Moloney-murine sarcoma virus (M-MSV) induced-tumours by adoptive transfer of ricin-treated T-lymphocytes. British Journal of Cancer. 55: 413-9. PMID 2437947 DOI: 10.1038/Bjc.1987.81 |
0.762 |
|
| 1985 |
Zanovello P, Cerundolo V, Strada G, Fabbris R, Collavo D. Tumor therapy by adoptive transfer of ricin-treated cytotoxic T lymphocytes in mice International Journal of Immunopharmacology. 7: 406. DOI: 10.1016/0192-0561(85)90464-3 |
0.728 |
|
| 1985 |
Cerundolo V, Zanovello P, Giunta M, Fabbris R, Collavo D. In vitro transfer of ricin toxicity by tumor-specific cytotoxic T lymphocytes International Journal of Immunopharmacology. 7: 406. DOI: 10.1016/0192-0561(85)90463-1 |
0.729 |
|
| 1984 |
Ronchese F, D'Andrea E, Collavo D, De Rossi A, Zanovello P, Chieco-Bianchi L. Tolerance to viral antigens in Mov-13 mice carrying endogenized Moloney-murine leukemia virus. Cellular Immunology. 83: 379-88. PMID 6607132 DOI: 10.1016/0008-8749(84)90317-4 |
0.687 |
|
| 1984 |
Collavo D, Ronchese F, Zanovello P, Cerundolo V, Biasi G. Reduction in precursors of cytotoxic T lymphocytes and of cells with natural killer-like activity in spleens of cyclophosphamide-treated mice. International Journal of Immunopharmacology. 6: 529-34. PMID 6334044 DOI: 10.1016/0192-0561(84)90092-4 |
0.758 |
|
| 1984 |
Zanovello P, D'Andrea E, Ronchese F, Rossi AD, Collavo D, Chieco-Bianchi L. Role of infectious virus expression and immune response in retrovirus-induced oncogenesis. Tumori. 70: 1-8. DOI: 10.1177/030089168407000101 |
0.69 |
|
| 1983 |
Chieco-Bianchi L, D'Andrea E, De Rossi A, Zanovello P, Ronchese F, Collavo D. Natural history of M-MSV tumors in mice carrying endogenized Moloney leukemia virus. Haematology and Blood Transfusion. 28: 275-9. PMID 6602736 DOI: 10.1007/978-3-642-68761-7_51 |
0.675 |
|
| 1981 |
Biasi G, Collavo D, Zanovello P, Chieco-Bianchi L. Leukemia-cell rejection due to T-region encoded antigens. Immunogenetics. 12: 433-43. PMID 6971250 DOI: 10.1007/Bf01561686 |
0.693 |
|
| 1980 |
Collavo D, Zanovello P, Leuchars E, Davies AJS, Chieco-Bianchi L, Biasi G. Moloney Murine Sarcoma Virus Oncogenesis in T-Lymphocyte-Deprived Mice: Biologic and Immunologic Studies Journal of the National Cancer Institute. 64: 97-104. DOI: 10.1093/Jnci/64.1.97 |
0.669 |
|
| 1979 |
Biasi G, Collavo D, Zanovello P, Colombatti A, Chieco-Bianchi L. Lack of T-cell mediated cytotoxicity in M-MSV system depending on H-2 haplotypes. Journal of Immunogenetics. 6: 341-51. PMID 315438 DOI: 10.1111/J.1744-313X.1979.Tb00689.X |
0.66 |
|
| Show low-probability matches. |